Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 EUR | +3.83% | +4.20% | +3.83% |
04-30 | Emak best performer; Bialetti trailing. | AN |
03-19 | Bioera tops post-accounts; goes down Restart | AN |
Evolution of the average Target Price on Emak S.p.A.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock Market
- Equities
- EM Stock
- Consensus Emak S.p.A.